Resolving neuroinflammatory and social deficits in ASD model mice: Dexmedetomidine downregulates NF-κB/IL-6 pathway via α2AR
Article in Brain Behavior and Immunity (March 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis
Article in Brain Research (September 2023)
IL-34 exacerbates pathogenic features of Alzheimer’s disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice
Article in Biomedicine & Pharmacotherapy (September 2023)